Fakhreddin Jamali

5.2k total citations · 1 hit paper
124 papers, 4.1k citations indexed

About

Fakhreddin Jamali is a scholar working on Pharmacology, Pharmacology and Oncology. According to data from OpenAlex, Fakhreddin Jamali has authored 124 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pharmacology, 41 papers in Pharmacology and 34 papers in Oncology. Recurrent topics in Fakhreddin Jamali's work include Pharmacogenetics and Drug Metabolism (39 papers), Drug Transport and Resistance Mechanisms (31 papers) and Analytical Chemistry and Chromatography (29 papers). Fakhreddin Jamali is often cited by papers focused on Pharmacogenetics and Drug Metabolism (39 papers), Drug Transport and Resistance Mechanisms (31 papers) and Analytical Chemistry and Chromatography (29 papers). Fakhreddin Jamali collaborates with scholars based in Canada, Iran and United States. Fakhreddin Jamali's co-authors include Waheed Asghar, Sam Harirforoosh, Reza Mehvar, Robert T. Foster, F. M. Pasutto, Anthony S. Russell, Neal M. Davies, Matthew Wright, Saeed Sattari and Dion R. Brocks and has published in prestigious journals such as PEDIATRICS, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Fakhreddin Jamali

122 papers receiving 3.9k citations

Hit Papers

Adverse Effects of Nonsteroidal Antiinflammatory Drugs: A... 2014 2026 2018 2022 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications
    2014 662 citations Waheed Asghar, Fakhreddin Jamali et al. Journal of Pharmacy & Pharmaceutical Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fakhreddin Jamali Canada 35 1.4k 1.2k 998 687 681 124 4.1k
Dion R. Brocks Canada 37 830 0.6× 844 0.7× 527 0.5× 1.0k 1.5× 790 1.2× 139 4.3k
Kamal K. Midha Canada 29 894 0.6× 671 0.5× 771 0.8× 1.1k 1.5× 530 0.8× 75 5.2k
Aziz Karim United States 37 1.2k 0.9× 722 0.6× 248 0.2× 1.2k 1.8× 668 1.0× 127 5.5k
Dafang Zhong China 36 1.2k 0.8× 1.1k 0.9× 892 0.9× 1.8k 2.6× 913 1.3× 266 5.2k
Roger K. Verbeeck Belgium 36 1.2k 0.9× 1.4k 1.1× 207 0.2× 647 0.9× 817 1.2× 156 4.7k
Hye Suk Lee South Korea 39 676 0.5× 935 0.8× 415 0.4× 2.4k 3.5× 529 0.8× 254 5.1k
Reginald F. Frye United States 40 924 0.7× 1.8k 1.5× 236 0.2× 1.0k 1.5× 924 1.4× 160 5.2k
Reza Mehvar United States 28 456 0.3× 732 0.6× 661 0.7× 766 1.1× 653 1.0× 143 3.4k
Garry G. Graham Australia 31 977 0.7× 910 0.7× 241 0.2× 1.3k 1.9× 678 1.0× 115 5.0k
GT Tucker United Kingdom 27 675 0.5× 1.4k 1.2× 451 0.5× 648 0.9× 715 1.0× 88 3.3k

Countries citing papers authored by Fakhreddin Jamali

Since Specialization
Citations

This map shows the geographic impact of Fakhreddin Jamali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fakhreddin Jamali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fakhreddin Jamali more than expected).

Fields of papers citing papers by Fakhreddin Jamali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fakhreddin Jamali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fakhreddin Jamali. The network helps show where Fakhreddin Jamali may publish in the future.

Co-authorship network of co-authors of Fakhreddin Jamali

This figure shows the co-authorship network connecting the top 25 collaborators of Fakhreddin Jamali. A scholar is included among the top collaborators of Fakhreddin Jamali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fakhreddin Jamali. Fakhreddin Jamali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jamali, Fakhreddin, et al.. (2023). Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition. Journal of Pharmacy & Pharmaceutical Sciences. 26. 11137–11137. 11 indexed citations
3.
4.
Jamali, Fakhreddin, et al.. (2019). Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs. Inflammopharmacology. 27(5). 903–910. 9 indexed citations
5.
Jamali, Fakhreddin, et al.. (2018). Clinical Outcomes of Aspirin Interaction with Other Non-Steroidal Anti-Inflammatory Drugs: A Systematic Review. Journal of Pharmacy & Pharmaceutical Sciences. 21(1s). 48s–73s. 21 indexed citations
6.
Asghar, Waheed, Ali Aghazadeh‐Habashi, & Fakhreddin Jamali. (2017). Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis. Inflammopharmacology. 25(5). 543–553. 23 indexed citations
7.
Asghar, Waheed & Fakhreddin Jamali. (2014). The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review. Inflammopharmacology. 23(1). 1–16. 67 indexed citations
8.
Jamali, Fakhreddin, et al.. (2010). Inflammation Alters Angiotensin Converting Enzymes (ACE and ACE-2) Balance in Rat Heart. Inflammation. 34(6). 609–613. 29 indexed citations
9.
Dryden, William F., et al.. (2007). Effects of angiotensin II blockade on inflammation‐induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers. British Journal of Pharmacology. 153(1). 90–99. 30 indexed citations
10.
Daneshtalab, Noriko, Richard Lewanczuk, Anthony S. Russell, & Fakhreddin Jamali. (2006). Drug‐Disease Interactions: Losartan Effect Is Not Downregulated by Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 46(11). 1344–1355. 18 indexed citations
11.
Stinson, Dora A., et al.. (2003). EXCRETION OF ACEBUTOLOL AND ITS MAJOR METABOLITE DIACETOLOL INTO INFANT BLOOD CIRCULATION AND THE BREAST MILK. Iranian journal of pharmaceutical research. 2(3). 141–144. 1 indexed citations
12.
Jamali, Fakhreddin, et al.. (2003). Disease–drug interaction: Reduced response to propranolol despite increased concentration in the rat with inflammation. Journal of Pharmaceutical Sciences. 92(5). 1077–1084. 36 indexed citations
13.
Jamali, Fakhreddin, et al.. (2000). Methoxyflurane anesthesia augments the chronotropic and dromotropic effects of verapamil.. PubMed. 2(1). 30–5. 13 indexed citations
14.
Eliot, Lise & Fakhreddin Jamali. (1999). Pharmacokinetics and Pharmacodynamics of Nifedipine in Untreated and Atorvastatin-Treated Hyperlipidemic Rats. Journal of Pharmacology and Experimental Therapeutics. 291(1). 188–193. 31 indexed citations
15.
Jamali, Fakhreddin, Ray Lovlin, & Gunnar Åberg. (1997). Bi-directional chiral inversion of ketoprofen in CD-1 mice. Chirality. 9(1). 29–31. 44 indexed citations
16.
Mehvar, Reza & Fakhreddin Jamali. (1997). Bioequivalence of Chiral Drugs. Clinical Pharmacokinetics. 33(2). 122–141. 22 indexed citations
17.
Brocks, Dion R. & Fakhreddin Jamali. (1994). Etodolac Clinical Pharmacokinetics. Clinical Pharmacokinetics. 26(4). 259–274. 47 indexed citations
18.
Alessi‐Severini, Silvia, Ronald T. Coutts, Fakhreddin Jamali, & Franco M. Pasutto. (1992). High-performance liquid chromatographic analysis of methocarbamol enantiomers in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 582(1-2). 173–179. 21 indexed citations
19.
Jamali, Fakhreddin, et al.. (1990). Ketoprofen Pharmacokinetics in Humans: Evidence of Enantiomeric Inversion and Lack of Interaction. Journal of Pharmaceutical Sciences. 79(5). 460–461. 48 indexed citations
20.
Jamali, Fakhreddin. (1988). Research methodology in NSAID monitoring: plasma concentrations of chiral drugs.. PubMed. 17. 71–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dion R. Brocks Breakdown of academic impact, for papers by Kamal K. Midha Breakdown of academic impact, for papers by Aziz Karim Breakdown of academic impact, for papers by Dafang Zhong Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Hye Suk Lee Breakdown of academic impact, for papers by Reginald F. Frye Breakdown of academic impact, for papers by Reza Mehvar Breakdown of academic impact, for papers by Garry G. Graham Breakdown of academic impact, for papers by GT Tucker
Rankless by CCL
2026